XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Narrative (Details) - Focused Company Plan [Member] - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Apr. 03, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]        
Restructuring cost incurred to date $ 2,300      
Biopharma [Member]        
Restructuring Cost and Reserve [Line Items]        
Restructuring cost incurred to date 875      
Restructuring costs incurred 20 $ 712 $ 79 $ 64
Corporate Enabling Functions [Member]        
Restructuring Cost and Reserve [Line Items]        
Expected restructuring cost 1,800      
Go-to Market Model [Member]        
Restructuring Cost and Reserve [Line Items]        
Expected restructuring cost 1,100      
Manufacturing Optimization [Member]        
Restructuring Cost and Reserve [Line Items]        
Expected restructuring cost $ 800      
Percentage of expected costs to be non-cash 25.00%